Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit

Core Insights - Daxor Corporation is participating in the Maxim Growth Summit, a premier small-cap investor event featuring 40 promising healthcare companies [1][7] - The event will take place on October 22-23, 2025, at the Hard Rock Hotel in New York City, with Daxor's CEO Michael Feldschuh engaging with institutional investors [1][2] Company Overview - Daxor Corporation focuses on addressing the healthcare industry's challenge of accurately measuring blood volume, which is crucial for optimal patient care and reducing hospital stays [4] - The company has developed a patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic system that provides real-time, precise data, enabling clinicians to make better treatment decisions [4] - Daxor operates a state-of-the-art 20,000-square-foot manufacturing facility in the U.S. and is ISO certified, positioning it for market expansion [4]